Securities Code: 002332 Securities Abbreviation: Xianju Pharmaceutical Announcement No.: 2026-011
Zhejiang Xianju Pharmaceutical Co., Ltd. Announcement on Continuing to Provide Guarantees for Wholly-Owned Subsidiaries
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from any false representations, misleading statements, or material omissions.
I. Overview of Guarantee Situation
-
Zhejiang Xianju Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the second meeting of the Ninth Board of Directors on April 21, 2026, and reviewed and approved the "Proposal on Continuing to Provide Guarantees for Wholly-Owned Subsidiary Taizhou Xianju Pharmaceutical Co., Ltd." The Company's previous maximum guarantee of RMB 70 million for its wholly-owned subsidiary Taizhou Xianju Pharmaceutical Co., Ltd. (hereinafter referred to as "Taizhou Xianju") is about to expire. Considering its production, operation, and financing needs, the Company proposes to continue to provide a guarantee for Taizhou Xianju's financing business, with a maximum guarantee amount not exceeding RMB 70 million and a guarantee period of three years. The guarantee for Taizhou Xianju is within the scope of the Board of Directors' approval authority and does not require submission to the Company's general meeting of shareholders for deliberation.
-
The Company held the second meeting of the Ninth Board of Directors on April 21, 2026, and reviewed and approved the "Proposal on Continuing to Provide Guarantees for Wholly-Owned Subsidiary Xianju Xianyao Trading Co., Ltd." The Company's previous maximum guarantee of RMB 40 million for its wholly-owned subsidiary Xianju Xianyao Trading Co., Ltd. (hereinafter referred to as "Xianyao Trading") is about to expire. To ensure the effective operation and enhance sales scale of this subsidiary, the Company proposes to continue to provide a guarantee for Xianyao Trading's financing from relevant financial institutions, with a maximum guarantee amount not exceeding RMB 40 million and a guarantee period of three years. Xianyao Trading's asset-liability ratio exceeds 70%. According to the China Securities Regulatory Commission's "Supervision Guidelines for Listed Companies No. 8 - Supervision Requirements for Capital Transactions and External Guarantees of Listed Companies" and the "Articles of Association," the guarantee for Xianyao Trading requires approval from the Company's 2025 annual general meeting of shareholders.
II. Basic Information of Guaranteed Parties
(I) Taizhou Xianju Pharmaceutical Co., Ltd.